Increased risk of end-stage renal disease in patients with renal cell carcinoma: A 12-year nationwide follow-up study

Medicine (United States)

Volumn 93, Issue 8, 2014, Pages

  Hung, Peir Haur ^a,b   Tsai, Hung Bin ^c   Hung, Kuan Yu ^c   Muo, Chih Hsin ^d,e   Chung, Mu Chi ^f   Chang, Chao Hsiang ^d,e   Chung, Chi Jung ^e,g  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TAIWAN; CHRONIC KIDNEY FAILURE; KAPLAN MEIER METHOD; KIDNEY TUMOR; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; CARCINOMA, RENAL CELL; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84906095357     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000052     Document Type: Article

References (30)

1. Abouchacra S, Duguid WP, Somerville PJ. Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure. Clin Nephrol. 1993;39:340-342. (Pubitemid 23196943)
2. Abu-Romeh SH, al-Adnani MS, Asfar S. Renal cell carcinoma presenting with acute renal failure and IgA glomerulonephritis. Nephron. 1988;50:169-170.
3. Ahmed M, Solangi K, Abbi R, et al. Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis. J Am Soc Nephrol. 1997;8:848-852. (Pubitemid 27493600)
4. Anderson RG, Bueschen AJ, Lloyd LK, et al. Short-term and longterm changes in renal function after donor nephrectomy. J Urol. 1991;145:11-13.
5. Auguet T, Lorenzo A, Colomer E, et al. Recovery of minimal change nephrotic syndrome and acute renal failure in a patient withRenal cell carcinoma. Am J Nephrol. 1998;18:433-435. (Pubitemid 28442109)
6. Barlow LJ, Korets R, Laudano M, et al. Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis. BJU Int. 2010;106:489-492.
7. Chen J, Shi B, Zhang D, et al. The clinical characteristics of renal cell carcinoma in female patients. Int J Urol. 2009;16: 554-557.
8. Cho A, Lee JE, Kwon GY, et al. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for newonset chronic kidney disease after radical nephrectomy. Nephrol Dial Transplant. 2011;26:3496-3501.
9. Cudkowicz ME, Sayegh MH, Rennke HG. Membranous nephropathy in a patient with renal cell carcinoma. Am J Kidney Dis. 1991;17:349-351.
10. Donin NM, Suh LK, Barlow L, et al. Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma. BJU Int. 2012;109:379-383.
11. Funahashi Y, Hattori R, Yamamoto T, et al. Change in contralateral renal parenchymal volume 1 week after unilateral nephrectomy. Urology. 2009;74:708-712.
12. Haroun MK, Jaar BG, Hoffman SC, et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14: 2934-2941. (Pubitemid 37305656)
13. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7: 735-740. (Pubitemid 44283660)
14. Jeon HG, Jeong IG, Lee JW, et al. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors. Urology. 2009;74:1064-1068.
15. Kagan A, Sinay-Trieman L, Czernobilsky B, et al. Is the association between crescentic glomerulonephritis and renal cell carcinoma coincidental? Nephron. 1993;65:642-643. (Pubitemid 23341524)
16. Kuo HW, Tsai SS, Tiao MM, et al. Epidemiological features of CKD in Taiwan. Am J Kidney Dis. 2007;49:46-55.
17. Lee S, Jeon HG, Kwak C, et al. Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC). BJU Int. 2012;110:E28-E33.
18. Lee SJ, Richards NT. Nephrotic syndrome cured by renal biopsy. Nephrol Dial Transplant. 1992;7:265-266.
19. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93-99. (Pubitemid 29313142)
20. Mandel J, Kjellstrand CM. Long-term results of dialysis and transplantation in patients with end-stage renal failure from hypernephroma. Nephron. 1986;44:111-114. (Pubitemid 16043524)
21. Nishibara G, Sukemi T, Ikeda Y, et al. Nephrotic syndrome due to membranous nephropathy associated with renal cell carcinoma. Clin Nephrol. 1996;45:424. (Pubitemid 26187148)
22. Perazella MA, Moeckel GW. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol. 2010;30:570-581.
23. Pettus JA, Jang TL, Thompson RH, et al. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc. 2008;83:1101-1106.
24. Prassopoulos P, Cavouras D, Gourtsoyiannis N. Pre- and postnephrectomy kidney enlargement in patients with contralateral renal cancer. Eur Urol. 1993;24:58-61. (Pubitemid 23219967)
25. Shirasaki Y, Tsushima T, Saika T, et al. Kidney function after nephrectomy for renal cell carcinoma. Urology. 2004;64:43-47. (Pubitemid 38887575)
26. Sommer M, Schmidt R, Lambrecht E, et al. Rapidly progressive glomerulonephritis in a patient with advanced renal cell carcinoma. Nephrol Dial Transplant. 1998;13:2107-2109. (Pubitemid 28356786)
27. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14:197-207. (Pubitemid 36026310)
28. Vincenti F, Amend WJ, Kaysen G, et al. Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation. 1983;36:626-629. (Pubitemid 14216269)
29. Woldrich JM, Mallin K, Ritchey J, et al. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol. 2008;179:1709-1713.
30. Woodrow G, Innes A, Ansell ID, et al. Renal cell carcinoma presenting as nephrotic syndrome. Nephron. 1995;69:166-169.